The pathogenesis of DNT involves alterations in constitutional and somatic fibroblast growth factor receptor 1 (FGFR1) and activation of the MAP kinase signaling pathway, which may be helpful in guiding the way to targeted therapy [14]. Here, FGFR1 is linked to dysembryoplastic neuroepithelial tumor.